Full-Time

Sales Compensation Analyst

Confirmed live in the last 24 hours

IDEXX

IDEXX

5,001-10,000 employees

Develops veterinary diagnostics and laboratory services

No salary listed

Entry, Junior

Company Does Not Provide H1B Sponsorship

Portland, ME, USA

Hybrid

Candidates will be required to be on site 2 days a week (8 days a month) at our office in Westbrook, ME.

Category
Human Resources
People & HR
Required Skills
Customer Service
Requirements
  • superior analytical skills
  • problem-solving prowess
  • strong collaborative abilities
  • agility
  • technical aptitude
  • ability to learn new software and programs quickly
  • experience in incentive compensation and scenario modeling
  • self-starter with strong communication and customer service skills
  • highly organized with the ability to prioritize and maintain attention to detail
Responsibilities
  • drive efficiency and effectiveness of the direct and indirect sales teams
  • implement new compensation plans
  • make modifications to existing compensation plans
  • perform ad-hoc compensation analysis on developing trends within sales performance
  • create model scenarios to set up for future success
  • assist with the research and problem solving of sales and billing discrepancies
Desired Qualifications
  • Prior experience with Alteryx highly preferred
  • Use of Anaplan or another Incentive Compensation Management system would be ideal
  • Data gathering and analytical ability, including summarizing information and drawing appropriate conclusions
  • Experience with data transformation tools such as Alteryx or knowledge of languages such as SQL would be preferred
  • Experience with Salesforce or another CRM
  • Project management skills and the ability to collaborate and communicate with stakeholders from across the business
  • Bachelor’s Degree or equivalent combination of coursework and experience

IDEXX Laboratories, Inc. develops and sells products and services for animal health and water testing. Their offerings include in-clinic diagnostic tools, reference laboratory services, and practice management software aimed at veterinarians. These products help improve the efficiency and accuracy of veterinary diagnostics, which can enhance health outcomes for animals. IDEXX operates globally, with a strong presence in North America, Europe, and Asia, and generates revenue through direct sales to veterinary practices and recurring income from laboratory services and software subscriptions. Unlike many competitors, IDEXX focuses on a comprehensive range of solutions that support both companion animals and livestock, ensuring veterinarians have the necessary tools for high-quality care.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Westbrook, Maine

Founded

1983

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for telemedicine complements IDEXX's existing diagnostic solutions.
  • The rise of personalized medicine aligns with IDEXX's focus on innovative diagnostic solutions.
  • Growing pet insurance trends boost demand for IDEXX's advanced diagnostic products.

What critics are saying

  • Increased competition from companies like Zoetis and Heska could impact IDEXX's market share.
  • Rapid AI advancements may disrupt traditional diagnostics, affecting IDEXX's current product lines.
  • Economic instability in Europe and Asia could reduce spending on veterinary services.

What makes IDEXX unique

  • IDEXX offers a comprehensive range of veterinary diagnostic solutions and practice management software.
  • The company has a strong global presence, particularly in North America, Europe, and Asia.
  • IDEXX's Catalyst Platform provides critical insights for diagnosing endocrine disorders in canines.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Mental Health Support

Pet Insurance

Employee Stock Purchase Plan

Volunteer Paid Days Off

Company News

PR Newswire
Jun 5th, 2025
Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

WESTBROOK, Maine, June 5, 2025 /PRNewswire/ - IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst(R) Cortisol Test, which measures real-time quantitative cortisol concentrations to support the diagnosis of Addison's disease and diagnosis and management of Cushing's syndrome in dogs.

Daily Guardian
Feb 17th, 2025
South Korea Flow Cytometry Industry Trends, Key Players & Future Outlook: Rising Healthcare & Biotech Investments Drive South Korea Flow Cytometry Market Growth

February 2022: IDEXX Laboratories launched the Procyte One analyzer in South Korea, leveraging advanced flow cytometry laser technology.

ETF Daily News
Dec 4th, 2024
Quantbot Technologies LP Makes New $341,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Quantbot Technologies LP makes new $341,000 investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX).

Veterinary Practice News
Nov 12th, 2024
Industry partnership offers ACVIM residents free educational resources

The American College of Veterinary Internal Medicine (ACVIM) has partnered with IDEXX Laboratories, Inc. to endorse the SpringBoard program, offering complimentary, resident-focused educational resources.

MarketBeat
Oct 25th, 2024
Legacy Capital Group California Inc. Makes New $750,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Legacy Capital Group California Inc. makes new $750,000 investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX).